Chronic Central Infusion of Ghrelin Increases Hypothalamic Neuropeptide Y and Agouti-Related Protein mRNA Levels and Body Weight in Rats

Diabetes

Volumn 50, Issue 7-12, 2001, Pages 2438-2443

  Kamegai, Jun ^a   Tamura, Hideki ^a   Shimizu, Takako ^a   Ishii, Shinya ^a   Sugihara, Hitoshi ^a   Wakabayashi, Ichiji ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; AGOUTI-RELATED PROTEIN; GHRELIN; MESSENGER RNA; NEUROPEPTIDE Y; PEPTIDE; PEPTIDE HORMONE; PROTEIN; SIGNAL PEPTIDE;

ANIMAL; ARTICLE; BODY WEIGHT; DRUG ADMINISTRATION; DRUG EFFECT; EATING; GENE EXPRESSION; GENETICS; HYPOTHALAMUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BODY WEIGHT; DRUG ADMINISTRATION SCHEDULE; EATING; GENE EXPRESSION; HYPOTHALAMUS; INJECTIONS, INTRAVENTRICULAR; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEUROPEPTIDE Y; PEPTIDE HORMONES; PEPTIDES; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0035513696     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS: Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 20:68-100, 1099
2. Sanacora G, Kershaw M, Finkelstein JA, White JD: Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology 127:730-737, 1990
3. Mizuno TM, Makimura H, Silverstein J, Roberts JL, Lopingco T, Mobbs CV: Fasting regulates hypothalamic neuropeptide Y, agouti-related peptide, and proopiomelanocortin in diabetic mice independent of changes in leptin or insulin. Endocrinology 140:4551-4557, 1999
4. Hahn TM, Breininger JF, Baskin DG, Schwartz MW: Coexpression of AGRP and NPY in fasting-activated hypothalamic neurons. Nat Neurosci 1:271-272, 1998
5. Ebihara K, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Satoh N, Tamaki M, Yoshioka T, Hayase M, Matsuoka N, Aizawa-Abe M, Yoshimasa Y, Nakao K: Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action. Diabetes 48:2028-2033, 1999
6. Bergendahl M, Wiemann JN, Clifton DK, Huhtaniemi I, Steiner RA: Short-term starvation decreases POMC mRNA but does not alter GnRH mRNA in the brain of adult male rats. Neuroendocrinology 56:913-920, 1992
7. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, Baskin DG: Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46:2119-2123, 1997
8. Mizuno TM, Kleopoulos SP, Bergen HT, Roberts JL, Priest CA, Mobbs CV: Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 47:294-297, 1998
9. Bruno JF, Olchovsky D, White JD, Leidy JW, Song J, Berelowitz M: Influence of food deprivation in the rat on hypothalamic expression of growth-hormone releasing factor and somatostatin. Endocrinology 127: 2111-2117, 1990
10. Brady LS, Smith MA, Gold PW, Herkenham M: Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology 52:441-447, 1990
11. Clark JT, Kalra PS, Croeley WR, Kalra SP: Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 155:427-429, 1984
12. Rossi M, Kim MS, Morgan DGA, Small CJ, Edwards CMB, Sunter D, Abusnana S, Goldstone AP, Russell SH, Stanley SA, Smith DM, Yagaloff K, Ghatei MA, Bloom SR: A C-terminal fragment of agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology 139:4428-4431, 1998
13. Vaccarino FJ, Bloom FE, Rivier J, Vale W, Koob GF: Stimulation of food intake in rats by centrally administered hypothalamic growth hormone-releasing factor. Nature 314:167-168, 1985
14. Smith RG, Van Der Ploeg HT, Howard AD, Feighner SD, Cheng K, Hickey GJ, Wyvratt MJ: Peptidomimetic regulation of growth hormone secretion. Endocr Rev 18:621-645, 1997
15. Okada K, Ishii S, Minami S, Sugihara H, Shibasaki T, Wakabayashi I: Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats. Endocrinology 137:5155-5158, 1996
16. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong S-S, Chaung L-Y, Elbrecht A, Dashkevicz, M, Heavens R, Rigby M, Sirinathsinghji DJS, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LHT: A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273:974-977, 1996
17. Guan X-M, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJS, Smith RG, Van der Ploeg LHT, Howard AD: Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol Brain Res 48:23-29, 1997
18. Tannenbaum GS, Lapointe M, Beaudet A, Howard AD: Expression of growth hormone secretagogue-receptors by growth hormone-releasing hormone neurons in the mediobasal hypothalamus. Endocrinology 139: 4420-4423, 1998
19. Willesen MG, Kristensen P, Romer J: Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 70:306-310, 1999
20. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660, 1999
21. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I: Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 141:4797-4800, 2000
22. Chapman IM, Bach MA, Cauter EV, Farmer M, Krupa D, Taylor AM, Schilling LM, Cole KY, Skiles EH, Pezzoli SS, Hartman ML, Veldhuis JD, Gormley GJ, Thorner MO: Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretagogue (MK-0677) in healthy elderly subjects. J Clin Endorrinol Metab 81:4249-4257, 1996
23. Hickey GJ, Jacks TM, Schleim KD, Frazier E, Chen HY, Krupa D, Feeney W, Nargund RP, Patchett AA, Smith RG: Repeated administration of the GH secretagogue MK-0677 increases and maintains elevated IGF-I levels in beagles. J Endocrinol 152:183-192, 1997
24. Kamegai J, Minami S, Sugihara H, Wakabayashi I: Barrel rotation evoked by intracerebroventricular injection of somatostatin and arginine-vasopressin is accompanied by the induction of c-fos gene expression in the granular cells of rat cerebellum. Mol Brain Res 18:115-120, 1993
25. Kamegai J, Hasegawa O, Minami S, Sugihara H, Wakabayashi I: The growth hormone-releasing peptide KP-102 induces c-fos expression in the arcuate nucleus. Mol Brain Res 39:153-159, 1996
26. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. New York, Academic Press, 1986
27. Frohman LA, Downs TR, Chomczynski P: Regulation of growth hormone secretion. Front Neuroendocrinol 13:344-405, 1992
28. Tschop M, Smiley DL, Heiman ML: Ghrelin induces adiposity in rodents. Nature 407:908-913, 2000
29. Dickson SL, Leng G, Dyball RE, Smith RG: Central actions of peptide and non-peptide growth hormone secretagogues in the rat. Neuroendocrinology 61:36-43, 1995
30. Dickson SL, Luckman SM: Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology 138:771-777, 1997
31. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friednian JM: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155-1161, 1995
32. Mizuno TM, Bergen H, Funabashi T, Kleopoulos SP, Zhong YG, Bauman WA, Mobbs CV: Obese gene expression: reduction by fasting and stimulation by glucose in lean mice, and persistent elevation in acquired (diet-induced) and genetic (yellow agouti) obesity. Proc Natl Acad Sci U S A 93:3434-3438, 1996
33. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Morgan PJ, Trayhurn P: Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol 8:733-735, 1996
34. Ahima RS, Prabakaran D, Mantozoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS: Role of leptin in the neuroendocrine response to fasting. Nature 382:250-252, 1096
35. Mizuno TM, Mobbs CV: Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology 140:814-817, 1990
36. Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DGA, Ghatei MA, Bloom SR: The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141:4325-4328, 2000
37. Havel PJ, Hahn TM, Sindelar DK, Baskin DG, Dallman MF, Weigle DS, Schwartz MW: Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes 411:244-252, 2000